CAS: 5731-13-5; 4-Ethyl-[1,1-Biphenyl]-4-Carboxylic Acid

上下游产品

CAS号586-76-5 对溴苯甲酸 | CAS号63139-21-9 对乙基苯硼酸 | CAS号619-58-9 对碘苯甲酸 | CAS号22873-28-5 4-苯乙基溴化镁 | CAS号128860-87-7 2-(4'-acetylbip... | CAS号852-38-0 2-(4-联苯基)-5-苯基恶二唑 | CAS号5730-92-7 4-乙酰基-4-乙基联苯 | CAS号92-91-1 4-联苯乙酮 | CAS号92-52-4 联苯 | CAS号5707-44-8 4-乙基联苯 | CAS号92119-00-1 4'-ethyl-biphen...

4'-乙基-4-氰基联苯置于sodium Hydroxide体系中,化学反应生成 对乙基联苯甲酸
参考文献:De2535046
标题:De2535046

专利信息

专利号:WO-2006079916-A1
优先权日:2005-01-26
标 题 :Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
发明人：ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
权利人:PHARMACIA & UPJOHN CO LLC; ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; RAHMAN HAYAT; SCHWEITZER BARBARA ANN; TENBRINK RUTH ELIZABETH
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I): wherein A1, A2, A3, A4, A5, A6, A7, A8, X4, X6, R2, R4, R5, and R6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:US-9217012-B2
优先权日:2009-04-08
标题 :Inhibitors of protein tyrosine phosphatases
发明人：ZHANG ZHONG-YIN; ZHANG SHENG
权利人:ZHANG ZHONG-YIN; ZHANG SHENG; UNIV INDIANA RES & TECH CORP
摘要:Disclosed herein are compounds that selectively inhibit members of the PTP family of enzymes. Synthesized compounds demonstrated selective inhibition of TC-PTP. Also provided are methods of using the compounds and formulations containing the compounds. Also described is a fluorescence-tagged combinatorial library synthesis and screening method. And methods of using these compounds to effect enzyme activity both in cells and in vitro as well as method of using these compounds to treat diseases in human and animals.

专利号:US-7671085-B2
优先权日:2002-11-15
标 题 :Non-steroidal farnesoid X receptor modulators and methods for the use thereof
发明人：DOWNES MICHAEL R; EVANS RONALD M
权利人:SALK INST FOR BIOLOGICAL STUDI
摘要:The efficient regulation of cholesterol synthesis, metabolism, acquisition, and transport is an essential component of lipid homeostasis. The farnesoid X receptor (FXR) is a transcriptional sensor for bile acids, the primary product of cholesterol metabolism. Accordingly, the development of potent, selective, small molecule agonists, partial agonists, and antagonists of FXR would be an important step in further deconvoluting FXR physiology. In accordance with the present invention, the identification of novel potent FXR activators is described. Two derivatives of invention compounds, bearing stilbene or biaryl moieties, contain members that are the most potent FXR agonists reported to date in cell-based assays. These compounds are useful as chemical tools to further define the physiological role of FXR as well as therapeutic leads for the treatment of diseases linked to cholesterol, bile acids and their metabolism and homeostasis.

专利号:CN-102850263-B
优先权日:2012-10-10
标题 :A kind of photomagnetically controllable liquid crystal compound containing Schiff base structure in the terminal group of alkyl biphenyl and its synthesis method

专利号:CN-102850263-A
优先权日:2012-10-10
标 题 :A kind of photomagnetically controllable liquid crystal compound containing Schiff base structure in the terminal group of alkyl biphenyl and its synthesis method